Affiliate Disclosure: This content contains affiliate links to health providers and services. BestMedsHub may receive compensation when you click through and take action. This compensation may impact how and where products and providers appear on this site. BestMedsHub does not include all providers or products available in the marketplace. This information is not medical advice — always consult a qualified healthcare professional.
Short answer: Yes. Circle Medical diagnoses adult ADHD and, if clinically appropriate, after evaluation by a licensed clinician, can prescribe stimulant medications such as Adderall and Vyvanse in most of the 32 states it serves. The major exception: residents of Georgia, Ohio, Michigan, and North Carolina cannot receive controlled-substance prescriptions through the platform at all, under Circle Medical’s own published policy.
That one sentence contains most of what separates Circle Medical from the rest of the ADHD telehealth field. It is a primary-care practice rather than a psychiatry-only startup, it runs a structured three-appointment diagnostic protocol instead of a single video call, and it is unusually transparent about where its controlled-substance prescribing stops. This review covers how the pathway works, what it costs with and without insurance, where the state-level carve-outs bite, and what 1,279 Trustpilot reviewers actually complain about.
Regulatory note (verified June 2026): As of June 2026, DEA-registered telehealth providers can legally prescribe ADHD medications – including Schedule II stimulants like Adderall and Vyvanse – without a prior in-person visit, under temporary federal flexibilities extended through December 31, 2026. A permanent DEA rule is pending, and state laws and individual platform policies may be stricter.
What is Circle Medical?
Circle Medical Technologies is a San Francisco telehealth and in-person primary-care practice founded in 2015 and incubated at Y Combinator. Since November 2020 it has been majority-owned by WELL Health Technologies, a publicly traded Canadian health-tech company (TSX: WELL). That ownership matters for a category full of thinly capitalized startups: Circle Medical answers to a public-company parent with disclosure obligations, not an anonymous holding company.
The more important structural point is that Circle Medical is a primary-care platform that treats ADHD, not an ADHD-only prescribing funnel. Its clinicians also manage anxiety, sleep, weight, preventive care, and routine chronic conditions. For ADHD patients, that cuts both ways. The upside is continuity: the same practice can manage your blood pressure check and your stimulant follow-ups, and the clinical culture is general medicine rather than volume psychiatry. The trade-off is that you are seeing primary-care clinicians, not a dedicated psychiatric specialty group, which some patients with complex psychiatric histories may prefer.
The three-appointment ADHD pathway
Circle Medical does not sell a diagnosis. It sells a structured evaluation that may or may not end in one, and the company is upfront that ADHD treatment follows a three-appointment protocol:
- Appointment 1: intake. A licensed clinician takes your medical and psychiatric history, reviews symptoms and prior records, and screens for conditions that can mimic or complicate ADHD, such as anxiety, depression, or sleep disorders.
- Appointment 2: comprehensive assessment. A dedicated visit for the formal ADHD evaluation, going deeper on symptom history, functional impairment across work and home life, and standardized assessment.
- Appointment 3: diagnosis and treatment decision. The clinician reviews findings, delivers a diagnostic conclusion, and, where a diagnosis is confirmed, discusses treatment options. Medication, including Schedule II stimulants where state law and platform policy allow, is prescribed only if clinically appropriate, after evaluation by a licensed clinician.
It is worth being blunt about what this means: some patients will complete all three appointments and not receive an ADHD diagnosis, or will be offered non-stimulant treatment first. That is the protocol working as designed, not a failure of the service. Platforms that compress evaluation into a single short call have drawn regulatory scrutiny across the industry; Circle Medical’s slower pathway is the more defensible clinical posture, and you should budget for it in both time and money.
State availability and the controlled-substance carve-outs
Circle Medical offers telemedicine in 32 states. But availability for ADHD care specifically is more complicated than the headline number, and this is where most competitors get vague. Circle Medical publishes its restrictions, so we can be precise:
- Georgia, Ohio, Michigan, and North Carolina: Circle Medical does not prescribe controlled substances of any kind to residents of these four states. You can still be evaluated and treated for ADHD there, but stimulants such as Adderall and Vyvanse are off the table through this platform. If stimulant therapy is the goal and you live in one of these states, look elsewhere from the start.
- New Jersey: patients on Schedule II medications must complete an in-person follow-up visit every three months. Circle Medical has physical clinic presence, but if regular in-person visits are not practical for you, this requirement changes the math of an otherwise online service.
- The CVS problem: a practical friction patients repeatedly hit is that controlled-substance prescriptions cannot be e-sent to CVS pharmacies. If CVS is your default pharmacy, plan to designate a different one before your treatment appointment, because rerouting a Schedule II prescription after the fact is a documented source of delays and frustration.
None of these limits are unique failings. State telehealth law is a patchwork, and the ongoing stimulant shortages have made pharmacy fulfillment unpredictable industry-wide. What is unusual is that Circle Medical states its restrictions plainly on its own site rather than letting patients discover them at appointment three. For a fuller picture of the legal landscape, see our guide to the 2026 telehealth stimulant rules.
Pricing: cash pay vs. PPO insurance
Circle Medical runs an insurance-first model, which is rare in ADHD telehealth, where most competitors are cash-only subscriptions. Many PPO plans are accepted, and the company reports that roughly 75% of insured patients pay $40 or less per appointment. Cash-pay patients pay per visit rather than a monthly membership.
| Path | Cost |
|---|---|
| First appointment (cash) | $179 |
| Follow-up appointments (cash) | $120 each |
| Full three-appointment diagnostic pathway (cash) | About $419 total |
| Ongoing medication management (cash) | About $120 per month |
| With an accepted PPO plan | About 75% of insured patients pay $40 or less per appointment |
| Medicaid | Not accepted |
Two things stand out. First, the roughly $419 cash cost to reach a diagnosis is real money, and unlike a flat-fee evaluation, it is spread across three visits with no promised outcome at the end. Second, for insured patients the economics flip: an in-network ADHD evaluation for three copays of $40 or less is among the better deals in telehealth psychiatry-adjacent care. The hard stop is Medicaid, which Circle Medical does not accept in any state.
Reputation and complaints
Circle Medical holds a 3.7/5 rating on Trustpilot across 1,279 reviews as of June 2026. That is a genuinely mixed score: meaningfully better than the troubled ADHD-telehealth names of 2022 and 2023, but well short of the 4.5+ ratings the strongest telehealth brands maintain. Three complaint themes recur:
- Surprise billing. The most common grievance. Patients report being quoted one insurance estimate and billed another, or discovering after a visit that their plan processed it differently than expected. If you go the insurance route, verify your coverage with your insurer directly before the first appointment, not just through Circle Medical’s eligibility check.
- Pharmacy fulfillment friction. Prescriptions delayed, sent to the wrong pharmacy, or caught in the CVS routing limitation described above, compounded by nationwide stimulant shortages that no telehealth platform controls.
- Chatbot-only support. Routine support runs through in-app chat, and reviewers describe difficulty reaching a human quickly when something goes wrong, which stings most when the problem is a stalled controlled-substance refill.
On the regulatory side, the record is clean. As of June 2026 we found no government enforcement actions, warning letters, or significant litigation against Circle Medical in the public record, a meaningful distinction in a category where several high-profile competitors have faced federal investigations over their stimulant prescribing practices.
Who Circle Medical is best for
- Insured patients with an accepted PPO plan, who get a structured ADHD evaluation for roughly $40 or less per visit.
- People who want ADHD care inside a broader primary-care relationship rather than a single-condition app.
- Patients who value a deliberate, multi-visit diagnostic process and a platform with a clean legal record and public-company ownership.
- Residents of the 27 served states without controlled-substance restrictions who may need stimulant therapy, if clinically appropriate.
Who should look elsewhere
- Medicaid enrollees. Circle Medical does not accept Medicaid; if you need coverage-based care, start with insurance-first options on our comparison page instead.
- Residents of Georgia, Ohio, Michigan, or North Carolina seeking stimulant treatment, since the platform will not prescribe controlled substances there.
- Cash-pay patients on a tight budget, for whom about $419 to diagnosis plus roughly $120 per month ongoing is at the higher end of the category.
- Anyone who needs responsive human support, given the chat-first service model is the platform’s most consistent complaint.
The bottom line
Circle Medical earns its 9.1 editorial score by being the rare ADHD telehealth provider whose limits are published rather than discovered. The three-appointment protocol treats diagnosis as a clinical outcome instead of a product, the insurance pricing is genuinely strong, and the legal record is clean. The honest caveats: a 3.7/5 Trustpilot rating driven by billing surprises and support friction, no Medicaid, and a four-state controlled-substance blackout that disqualifies it outright for some readers. Weigh it against the full field on our page to compare ADHD telehealth providers before booking.